PDLIM2 and gastric cancer: We also assessed cell growth (Supplementary Figure S2A), invasion (Supplementary Figure S2B), cell cycle progression (Supplementary Figure S2C), and tumorigenicity (Supplementary Figure S2D) following PDLIM2 overexpression in NCI-N87 gastric cancer cells and obtained similar results to those described for MKN-45 cells.